Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine)

Medicare covers lymphocyte immune globulin, specifically anti‑thymocyte globulin (equine), for management of renal allograft rejection episodes. Coverage is limited to FDA‑approved products for this indication and intended as adjunctive therapy to conventional immunosuppressive regimens; investigational or non‑FDA‑approved formulations are not covered.

"Lymphocyte immune globulin, anti-thymocyte globulin (equine) is covered when used for management of renal allograft rejection episodes."

Sign up to see full coverage criteria, indications, and limitations.